M. Blank

发表

Immunomodulation of murine experimental SLE-like disease by interferon-γ

F. Nicoletti, Y. Shoenfeld, B. Gilburd, 1998, Lupus.

Tuftsin–phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model

I. Barshack, Y. Shoenfeld, N. Bragazzi, 2018, Clinical and experimental immunology.

Prevalence of anti-DFS 70 antibodies in patients with and without systemic autoimmune rheumatic diseases

Y. Shoenfeld, B. Gilburd, M. Mahler, 2018 .

The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture

R. K. Miller, Y. Shoenfeld, M. Blank, 2003, Lupus.

The role of anti‐endothelial cell antibodies in Kawasaki disease –in vitro and in vivo studies

Y. Shoenfeld, P. Youinou, A. Afek, 2002, Clinical and experimental immunology.

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

Y. Shoenfeld, M. Vilardell‐Tarrés, I. de Torres, 1996, Lupus.

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I

Y. Shoenfeld, S. Čučnik, B. Božič, 2015, Immunologic research.

Infectious antibodies in systemic lupus erythematosus patients

M. Boaz, Y. Shoenfeld, J. Anaya, 2009, Lupus.

Restricted specificity of anti-ribosomal P antibodies to SLE patients in Israel.

M. Ehrenfeld, Y. Shoenfeld, B. Gilburd, 2006, Clinical and experimental rheumatology.

Decrease in 14‐3‐3&eegr; protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib

Y. Shoenfeld, B. Gilburd, A. Marotta, 2019, Pharmacological research.

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression

Y. Shoenfeld, A. Doria, N. Agmon-Levin, 2010, Annals of the rheumatic diseases.

Carcinogen-induced trans activation of gene expression

T. Kleinberger, S. Lavi, S. Etkin, 1988, Molecular and cellular biology.

Induced with Hypericin Potential Mechanism for Mitotic Cell Death in Cancer Cells Enhanced Ubiquitinylation of Heat Shock Protein 90 as a

D. Meruelo, G. Lavie, M. Mandel, 2003 .

Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin.

D. Meruelo, G. Lavie, M. Mandel, 2003, Cancer research.

Immunization with anti‐neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration

A. Wiik, Y. Shoenfeld, M. Blank, 1995, Clinical and experimental immunology.

The presence of antiphospholipid antibodies in acute myocardial infarction

A. Lorber, Y. Shoenfeld, M. Blank, 1995, Lupus.

The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis.

N. Bragazzi, B. Gilburd, A. Marotta, 2018, Best practice & research. Clinical rheumatology.

Competitive Quenching: A Possible Novel Approach in Protecting RPE Cells from Damage During PDT

D. Weinberger, M. Lusky, A. Orenstein, 2005, Current eye research.

Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis.

A. Wiik, P. Fishman, R. Zigelman, 1995, Arthritis and rheumatism.

Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies.

Y. Shoenfeld, Y. Tomer, M. Blank, 1994, Arthritis and rheumatism.

Distribution of Two Common Idiotypes of Anticardiolipin Antibodies in Sera of Patients with Primary Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Monoclonal Gammopathies

G. Hughes, Y. Shoenfeld, M. Khamashta, 1992, Lupus.

The effect of cyclosporin A on early and late stages of experimental lupus.

Y. Shoenfeld, M. Ben-bassat, M. Blank, 1992, Arthritis and rheumatism.

Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype.

Y. Shoenfeld, M. Ben-bassat, M. Blank, 1991, Cellular immunology.

The production of human monoclonal anti-MMTV antibodies by in vitro immunization with anti-idiotypic antibodies.

Y. Shoenfeld, S. Chaitchik, I. Keydar, 1991, Immunology letters.

The Importance of the Pathogenic 16/6 Idiotype in the Induction of SLE in Naive Mice

Y. Shoenfeld, M. Blank, E. Mozes, 1990, Scandinavian journal of immunology.

The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody

Y. Shoenfeld, E. Mozes, B. Sredni, 1990, Clinical and experimental immunology.

Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis.

R. Nussenblatt, Y. Shoenfeld, A. Palestine, 1990, Clinical immunology and immunopathology.

The role of the human anti-DNA idiotype 16/6 in autoimmunity.

D. Isenberg, Y. Shoenfeld, M. Blank, 1989, Clinical immunology and immunopathology.

A human monoclonal anti-DNA antibody derived from a patient with polymyositis having the common lupus 16/6 idiotype.

S. Argov, Y. Shoenfeld, S. Sukenik, 1988, Immunology letters.

Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell.

Y. Shoenfeld, B. Gilburd, Y. Tomer, 1995, Arthritis and rheumatism.

Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis

L. Leibovici, Y. Shoenfeld, M. Blank, 2007, Lupus.

Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.

Y. Shoenfeld, S. Praprotnik, A. Eldor, 2002, Arthritis and rheumatism.

Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis.

Y. Shoenfeld, S. Praprotnik, B. Rozman, 2000, Wiener klinische Wochenschrift.

The Infectious Origin of the Anti-Phospholipid Syndrome

R. Cervera, E. Israeli, M. Blank, 2015 .

Antiphospholipid Syndrome Infectious Origin

Y. Shoenfeld, M. Blank, R. Cervera, 2004, Journal of Clinical Immunology.

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.

E. Katchalski‐Katzir, Y. Shoenfeld, M. Blank, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

Y. Shoenfeld, G. Zandman-Goddard, M. Blank, 2009, Lupus.

Autoantibodies associated with reproductive failure

Y. Shoenfeld, M. Blank, 2004, Lupus.

Erythropoietin Response to Anemia as a Function of Age

E. Goldwasser, J. Spivak, S. Krantz, 1991, Journal of the American Geriatrics Society.

Effect of Intraoperative Arterial Hypotension on the Risk of Perioperative Stroke After Noncardiac Surgery: A Retrospective Multicenter Cohort Study

T. Houle, M. Eikermann, Karuna Wongtangman, 2021, Anesthesia and analgesia.

Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS

Y. Shoenfeld, D. Mevorach, M. Blank, 2007, Lupus.

Antiphospholipid syndrome in pregnancy--animal models and clinical implications.

Y. Shoenfeld, Y. Sherer, M. Blank, 1998, Scandinavian journal of rheumatology. Supplement.

Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.

Y. Shoenfeld, J. George, M. Blank, 1998, Journal of immunology.

Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure

Y. Shoenfeld, B. Gilburd, M. Mahler, 2017, Immunologic research.

IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus

A. Mantovani, Y. Shoenfeld, M. Blank, 2010, Annals of the rheumatic diseases.

sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia

Y. Shoenfeld, N. Agmon-Levin, R. Priori, 2014, Immunologic Research.

When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA)

Y. Shoenfeld, E. Israeli, M. Blank, 2012, Lupus.

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Y. Shoenfeld, M. Blank, J. S. Cohen, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The Association Between Anti‐Thyroid Antibodies and Pregnancy Loss

Y. Shoenfeld, M. Blank, A. Ornoy, 2001, American journal of reproductive immunology.

Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer

A. Korczyn, A. Nahum, Y. Shoenfeld, 2003, Lupus.

Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome

J. Piette, G. Hughes, Y. Shoenfeld, 2003, Journal of Clinical Immunology.

Antiprothrombin Antibodies are Associated with Pregnancy Loss in Patients with the Antiphospholipid Syndrome

Y. Shoenfeld, M. Blank, P. von Landenberg, 2003, American journal of reproductive immunology.

Induction and treatment of the antiphospholipid syndrome – lessons from animal models

Y. Shoenfeld, Y. Sherer, M. Blank, 2001, European journal of clinical investigation.

Anti-Angiogenic Activities of Hypericin in vivo: Potential for Ophthalmologic Applications

D. Meruelo, G. Lavie, A. Solomon, 2005, Angiogenesis.

Animal models for antiphospholipid syndrome in pregnancy.

Y. Shoenfeld, M. Blank, M. Blank, 1997, Rheumatic diseases clinics of North America.

Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).

Y. Shoenfeld, G. Valentini, E. Grunebaum, 1996, Israel journal of medical sciences.

The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies)

Y. Shoenfeld, D. Buskila, N. Rose, 1993, Immunologic research.

Manipulation of autoimmune diseases with T-suppressor cells: lessons from experimental SLE and EAE.

Y. Shoenfeld, R. Arnon, R. Aharoni, 1993, Immunology Letters.

ANTI-cancer Activities of Hypericin in the Dark¶

G. Lavie, M. Mandel, M. Blank, 2001, Photochemistry and photobiology.

Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.

A. Waisman, Y. Shoenfeld, E. Mozes, 1999, International immunology.

Pathogenic natural anti‐cardiolipin antibodies: the experience from monoclonal gammopathy

G. Valesini, M. Blank, R. Bakimer, 1994, Clinical and experimental immunology.

Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network.

M. Blank, G. Valesini, M. Blank, 1993, Annals of the rheumatic diseases.

Immunomodulation of Experimental APS: Lessons from Murine Models

Y. Shoenfeld, M. Blank, I. Krause, 1996, Lupus.

Treatment of systemic lupus erythematosus and antiphospholipid syndrome: from experimental models to patients' bedside.

Y. Shoenfeld, M. Blank, I. Krause, 1996, International archives of allergy and immunology.

Immunomodulation of experimental antiphospholipid syndrome.

Y. Shoenfeld, Y. Sherer, M. Blank, 1998, Scandinavian journal of rheumatology. Supplement.

Effect of Long-Acting Thromboxane Receptor Antagonist (BMS 180,291) on Experimental Antiphospholipid Syndrome

Y. Shoenfeld, M. Blank, M. Blank, 1994, Lupus.

Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)

A. Korczyn, A. Korczyn, Y. Shoenfeld, 2001, Clinical and experimental immunology.

Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus

R. Reifen, Y. Shoenfeld, D. Sklan, 1998, Lupus.

Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA.

A. Wiik, Y. Shoenfeld, Y. Levy, 1998, International immunology.

The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress

Y. Shoenfeld, D. Mevorach, A. Ornoy, 2010, Lupus.

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.

Y. Shoenfeld, Y. Levy, B. Weksler, 2001, International immunology.

Anti-endothelial cell antibodies in the sera of hyperprolactinemic women

Y. Shoenfeld, B. Weksler, A. Eldor, 1998, Lupus.

Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome.

Y. Shoenfeld, Y. Levy, J. George, 1998, Circulation.

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.

Y. Shoenfeld, A. Kornberg, M. Blank, 1994, Journal of immunology.

The putative role of cytokines in the induction of primary anti‐phospholipid syndrome in mice

P. Fishman, D. Sredni, Y. Shoenfeld, 1992, Clinical and experimental immunology.

Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome.

R. Reifen, Y. Shoenfeld, D. Sklan, 2000, Journal of autoimmunity.

Review : Modulation of experimental systemic lupus erythematosus with linomide

Y. Shoenfeld, Y. Levy, J. George, 1996, Lupus.

Antiphospholipid syndrome and the idiotypic network

G. Hughes, Y. Shoenfeld, M. Khamashta, 1995, Lupus.

Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.

Y. Shoenfeld, M. Ben-bassat, M. Blank, 1992, Journal of autoimmunity.

Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+).

Y. Shoenfeld, E. Mozes, A. Coates, 1991, Clinical immunology and immunopathology.

Common infectious agents prevalence in antiphospholipid syndrome

Y. Shoenfeld, N. Agmon-Levin, R. Cervera, 2009, Lupus.

Infectious origin of the antiphospholipid syndrome

Y. Shoenfeld, M. Blank, R. Cervera, 2005, Annals of the rheumatic diseases.

From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?

Y. Shoenfeld, M. Blank, A. Aron-Maor, 2005, Lupus.

“Competitive Quenching”: A Mechanism by Which Perihydroxylated Perylenequinone Photosensitizers Can Prevent Adverse Phototoxic Damage Caused by Verteporfin During Photodynamic Therapy

D. Weinberger, M. Sheves, N. Friedman, 2007, Photochemistry and photobiology.

Efficacy of intravenous immunoglobulin (IVIG) affinity‐purified anti‐desmoglein anti‐idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris

I. Barshack, Y. Shoenfeld, M. Blank, 2010, Clinical and experimental immunology.

Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris

Y. Shoenfeld, D. Mimouni, M. Blank, 2005, Clinical and experimental immunology.

Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.

P. Fishman, Y. Shoenfeld, Y. Levy, 1998, Arthritis and rheumatism.

Suppression of experimental systemic lupus erythematosus (SLE) with specific anti‐idiotypic antibody–saporin conjugate

Y. Shoenfeld, Y. Tomer, A. Manosroi, 1994, Clinical and experimental immunology.

Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE.

Y. Shoenfeld, R. Arnon, M. Blank, 1994, Autoimmunity.

D-penicillamine-induced autoantibodies in a mouse model.

Y. Shoenfeld, G. Tenenbaum, M. Blank, 1995, Clinical and experimental rheumatology.

Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome

J. Chapman, Y. Shoenfeld, S. Kivity, 2012, Lupus.

Adjuvants and autoimmunity

Y. Shoenfeld, N. Agmon-Levin, Y Shoenfeld, 2009, Lupus.

Induction of Tolerance to Experimental Anti‐Phospholipid Syndrome (APS) by Syngeneic Bone Marrow Cell Transplantation

Y. Shoenfeld, Y. Tomer, S. Slavin, 1995, Scandinavian journal of immunology.

Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin.

Y. Shoenfeld, M. Blank, A. Tincani, 1993, American journal of obstetrics and gynecology.

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).

P. Fishman, Y. Shoenfeld, M. Blank, 1992, The Journal of clinical investigation.

Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.

Y. Shoenfeld, J. George, B. Gilburd, 1997, International immunology.

AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease

M. Ehrenfeld, Y. Shoenfeld, M. Blank, 2001, Lupus.

Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies ( autoimmunity / autoantibodies / systemic lupus erythematosus / lupus anticoagulant )

Y. Shoenfeld, M. Blank, J. Cohen, 2022 .

Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies

A. Korczyn, Y. Shoenfeld, S. Shrot, 2002, Lupus.

Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule.

Y. Shoenfeld, B. Gilburd, A. Tincani, 2002, Arthritis and rheumatism.

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I.

Y. Shoenfeld, Y. Levy, J. George, 1998, Circulation.

Wavelength‐dependent Properties of Photodynamic Therapy Using Hypericin in vitro and in an Animal Model ¶

S. Kimel, A. Orenstein, G. Lavie, 2002 .

Wavelength-dependent Properties of Photodynamic Therapy Using Hypericin in vitro and in an Animal Model¶

S. Kimel, A. Orenstein, G. Lavie, 2002, Photochemistry and photobiology.

Antimetastatic activity of the photodynamic agent hypericin in the dark

D. Meruelo, A. Orenstein, G. Lavie, 2004, International journal of cancer.

ANTI‐cancer Activities of Hypericin in the Dark ¶

G. Lavie, M. Mandel, M. Blank, 2001 .

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)

Y. Shoenfeld, A. Doria, N. Agmon-Levin, 2013, Lupus.

Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome

L. Nahary, M. Arango, M. Blank, 2016, Immunologic Research.

The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them?

Y. Shoenfeld, M. Blank, I. Krause, 2000, Clinical and experimental rheumatology.

Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.

Y. Shoenfeld, Y. Levy, Y. Sherer, 2000, Clinical and experimental rheumatology.

Anti-cardiolipin antibody from a patient with antiphospholipid syndrome ( APS ) recognizes only an epitope expressed by cardio-lipin / 2-glycoprotein-I ( 2 GPI ) complex and induces APS

Y. Shoenfeld, Y. Levy, Y. Sherer, 2006 .

Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies

Y. Shoenfeld, Y. Levy, J. George, 1997, Lupus.

Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus.

Y. Shoenfeld, M. Blank, 2005, Rheumatology.

The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment.

A. Waisman, Y. Shoenfeld, E. Mozes, 1995, International immunology.

Idiotype specific T-cell lines inducing experimental systemic lupus erythematosus in mice.

Y. Shoenfeld, E. Mozes, M. Ben-bassat, 1991, Immunology.

Serum antibodies in epilepsy and seizure-associated disorders

J. Palace, Jacqueline A Palace, Y. Shoenfeld, 2005, Neurology.

In Vitro Effect of Anticardiolipin Autoantibodies Upon Total and Pulsatile Placental hCG Secretion During Early Pregnancy

Y. Shoenfeld, M. Blank, R. Shurtz-Swirski, 1993, American journal of reproductive immunology.

Prolactin’s role in the pathogenesis of the antiphospholipid syndrome

Y. Shoenfeld, N. Agmon-Levin, R. Cervera, 2010, Lupus.

Antiphosphatidylserine antibodies and reproductive failure

Y. Shoenfeld, M. Blank, 2004, Lupus.

The Effects of IgG Purified from Women with SLE and Associated Pregnancy Loss on Rat Embryos in Culture

Y. Shoenfeld, A. Ornoy, Z. Blumenfeld, 2002, American journal of reproductive immunology.

Molecular mimicry in systemic lupus erythematosus

Y. Shoenfeld, N. Agmon-Levin, Y Shoenfeld, 2009, Lupus.

Inhibition of diabetes in NOD mice by idiotypic induction of SLE.

I. Cohen, Y. Shoenfeld, B. Gilburd, 1999, Journal of autoimmunity.

Oxidized low‐density lipoprotein (Ox‐LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)

Y. Shoenfeld, J. George, M. Blank, 1997, Clinical and experimental immunology.

A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants.

M. Ehrenfeld, Y. Shoenfeld, B. Gilburd, 1999, The Journal of rheumatology.

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain.

A. Tenenbaum, E. Fisman, M. Motro, 2000, The American journal of cardiology.

Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis.

R. Nussenblatt, Y. Shoenfeld, A. Palestine, 1992, International archives of allergy and immunology.

Novel therapeutic compound tuftsin–phosphorylcholine attenuates collagen‐induced arthritis

I. Barshack, Y. Shoenfeld, M. Blank, 2016, Clinical and experimental immunology.

The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome.

Y. Shoenfeld, O. Yodfat, M. Blank, 1996, Clinical immunology and immunopathology.

sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia

N. Agmon-Levin, R. Priori, G. Valesini, 2014, Immunologic Research.

Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies.

Y. Shoenfeld, A. Tincani, M. Blank, 1994, The Journal of rheumatology.

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I

B. Božič, G. Valesini, J. C. Cohen Tervaert, 2014, Immunologic Research.

Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure

B. Gilburd, M. Mahler, O. Shovman, 2016, Immunologic Research.

Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus

Y. Shoenfeld, A. Perl, M. Blank, 2009, Lupus.

Antibodies to the cytoplasm, cell membrane and nuclear membrane of malignant neoplasms in pooled normal human polyspecific immunoglobulin G.

I. Barshack, P. Fishman, Y. Shoenfeld, 1999, International Journal of Oncology.

Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study

M. Conforti, Y. Shoenfeld, M. Blank, 2007, Annals of the rheumatic diseases.

Immunomodulation of experimental autoimmune diseases via oral tolerance.

Y. Shoenfeld, M. Blank, M. Blank, 2000, Critical reviews in immunology.

Cross‐Reactive Epitopes on β2‐Glycoprotein‐I and Saccharomyces cerevisiae in Patients with the Antiphospholipid Syndrome

Y. Shoenfeld, M. Blank, R. Cervera, 2007, Annals of the New York Academy of Sciences.

TNF αDNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome

Y. Shoenfeld, M. Blank, M. Blank, 2003, Lupus.

Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells.

Y. Shoenfeld, P. Youinou, Yves Renaudineau, 2000, The Israel Medical Association journal : IMAJ.

Peptide immunotherapy in autoimmune diseases.

Y. Shoenfeld, M. Blank, I. Krause, 2000, Drug News and Perspectives.

New treatment avenues: oral tolerance--mechanisms and applicability to human diseases.

Y. Shoenfeld, M. Blank, I. Krause, 1999, The Israel Medical Association journal : IMAJ.

Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.

Y. Shoenfeld, M. Blank, Y. Tomer, 1995, The Journal of rheumatology.

Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome.

Y. Shoenfeld, B. Gilburd, I. Marai, 2003, Human Antibodies.

Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice.

Y. Shoenfeld, E. Mozes, N. Talal, 1990, The Journal of rheumatology.

Anti‐citrullinated‐protein‐antibody‐specific intravenous immunoglobulin attenuates collagen‐induced arthritis in mice

I. Barshack, Y. Shoenfeld, M. Blank, 2015, Clinical and experimental immunology.